Amendment: SEC Form SC 13G/A filed by Elevance Health Inc.

11/14/24 1:22:35 PM ET

Medical Specialities

Health Care

Get the next $ELV alert in real time by email

SC 13G/A 1 elv13gasep24.txt UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 SCHEDULE 13G Under the Securities Exchange Act of 1934 (Amendment No. 1) ELEVANCE HEALTH INC (Name of Issuer) COMMON STOCK (Title of Class of Securities) 036752103 (CUSIP NUMBER) September 30, 2024 (Date of Event which Requires Filing of Statement) Check the appropriate box to designate the Rule pursuant to which this Schedule is filed: [x] Rule 13d - 1(b) Rule 13d - 1(c) Rule 13d - 1(d) 1. Name of Reporting Person T. ROWE PRICE ASSOCIATES, INC. 52-0556948 2. Check the Appropriate Box if a Member of a Group NOT APPLICABLE 3. SEC Use Only 4. Citizenship or Place of Organization Maryland Number of Shares Beneficially Owned by Each Reporting Person With 5. Sole Voting Power* 9,781,863 6. Shared Voting Power* 0 7. Sole Dispositive Power* 10,147,282 8. Shared Dispositive Power 0 9. Aggregate Amount Beneficially Owned by Each Reporting Person 10,171,136 10. Check Box if the Aggregate Amount in Row (9) Excludes Certain Shares NOT APPLICABLE 11. Percent of Class Represented by Amount in Row 9 4.4% 12. Type of Reporting Person IA *Any shares reported in Items 5 and 6 are also reported in Item 7. Item 1(a) Name of Issuer: ELEVANCE HEALTH INC Item 1(b) Address of Issuer's Principal Executive Offices: 220 VIRGINIA AVENUE, INDIANAPOLIS, INDIANA 46204 Item 2(a) Name of Person(s) Filing: (1) T. ROWE PRICE ASSOCIATES, INC. (Price Associates) Item 2(b) Address of Principal Business Office: 100 E. Pratt Street, Baltimore, MD 21202 Item 2(c) Citizenship or Place of Organization: (1) Maryland Item 2(d) Title of Class of Securities: COMMON STOCK Item 2(e) Cusip Number: 036752103 Item 3: The person filing this Schedule 13G is an: X Investment Adviser registered under Section 203 of the Investment Advisers Act of 1940 Item 4: Reference is made to Items 5-11 on the preceding pages of this Schedule 13G. Item 5: Ownership of Five Percent or Less of a Class This statement is being filed to report the fact that, as of the date of this report, the reporting person(s) has (have) ceased to be the beneficial owner of more than five percent of the class of securities. Item 6: Ownership of More than Five Percent on Behalf of Another Person (1) Price Associates does not serve as custodian of the assets of any of its clients; accordingly, in each instance only the client or the client's custodian or trustee bank has the right to receive dividends paid with respect to, and proceeds from the sale of, such securities. The ultimate power to direct the receipt of dividends paid with respect to, and the proceeds from the sale of, such securities, is vested in the individual and institutional clients which Price Associates serves as investment adviser. Any and all discretionary authority which has been delegated to Price Associates may be revoked in whole or in part at any time. Except as may be indicated if this is a joint filing with one of the registered investment companies sponsored by Price Associates which it also serves as investment adviser ("T. Rowe Price Funds"), not more than 5% of the class of such securities is owned by any one client subject to the investment advice of Price Associates. Item 7: Identification and Classification of the Subsidiary Which Acquired the Security Being Reported on By the Parent Holding Company. Not Applicable Item 8: Identification and Classification of Members of the Group Not Applicable Item 9: Notice of Dissolution of Group Not Applicable Item 10: Certification By signing below I certify that, to the best of my knowledge and belief, the securities referred to above were acquired in the ordinary course of business and were not acquired and are not held for the purpose of or with the effect of changing or influencing the control of the issuer of the securities and were not acquired and are not held in connection with or as a participant in any transaction having that purpose or effect. T. Rowe Price Associates, Inc. hereby declares and affirms that the filing of Schedule 13G shall not be construed as an admission that Price Associates is the beneficial owner of the securities referred to, which beneficial ownership is expressly denied. Signature. After reasonable inquiry and to the best of my knowledge and belief, I certify that the information set forth in this statement is true, complete and correct. T. ROWE PRICE ASSOCIATES, INC. Date: November 14, 2024 Signature: /s/ Ellen York Name & Title: Ellen York, Vice President 09/30/2024

Get the next $ELV alert in real time by email

Recent Analyst Ratings for

$ELV

Date	Price Target	Rating	Analyst
5/20/2026	$498.00	Hold → Buy	Deutsche Bank
4/29/2026	$435.00	Neutral → Buy	BofA Securities
4/8/2026	$345.00	In-line	Evercore ISI
2/3/2026	$358.00	Outperform → Sector Perform	RBC Capital Mkts
1/8/2026	$425.00	Peer Perform → Outperform	Wolfe Research
12/19/2025	$320.00	Buy → Hold	Deutsche Bank
10/14/2025		Neutral	Goldman
7/21/2025		Buy → Hold	Argus

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Elevance Health Inc.

11/14/24 1:22:35 PM ET

$ELV

Medical Specialities

Health Care

Get the next $ELV alert in real time by email

Recent Analyst Ratings for

$ELV

Date	Price Target	Rating	Analyst
5/20/2026	$498.00	Hold → Buy	Deutsche Bank
4/29/2026	$435.00	Neutral → Buy	BofA Securities
4/8/2026	$345.00	In-line	Evercore ISI
2/3/2026	$358.00	Outperform → Sector Perform	RBC Capital Mkts
1/8/2026	$425.00	Peer Perform → Outperform	Wolfe Research
12/19/2025	$320.00	Buy → Hold	Deutsche Bank
10/14/2025		Neutral	Goldman
7/21/2025		Buy → Hold	Argus

More analyst ratings

Amendment: SEC Form SC 13G/A filed by Elevance Health Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ELV

Amendment: SEC Form SC 13G/A filed by Elevance Health Inc.

Crush Q1 2026 with the Best AI Superconnector

Recent Analyst Ratings for
$ELV

$ELV
SEC Filings

Elevance Health Inc. filed SEC Form 8-K: Submission of Matters to a Vote of Security Holders

SEC Form 10-Q filed by Elevance Health Inc.

Elevance Health Inc. filed SEC Form 8-K: Results of Operations and Financial Condition, Financial Statements and Exhibits

$ELV
Insider Trading

CAO & Controller Penczek Ronald W exercised 1,531 shares at a strike of $294.30 and sold $617,192 worth of shares (1,531 units at $403.13) (SEC Form 4)

Director Schulman Amy W was granted 563 shares, increasing direct ownership by 258% to 781 units (SEC Form 4)

Director Schneider Ryan M. was granted 563 shares, increasing direct ownership by 9% to 7,163 units (SEC Form 4)

$ELV
Analyst Ratings

Elevance Health upgraded by Deutsche Bank with a new price target

Elevance Health upgraded by BofA Securities with a new price target

Evercore ISI initiated coverage on Elevance Health with a new price target

$ELV
Press Releases

Elevance Health Expands Access to Digital Tools, Helping Bridge the Healthcare Digital Divide

Elevance Health Advances Efforts to Close Critical Gaps in Mental Health Care

Elevance Health Names Best in Class Primary Care Practices in Care Provider Recognition Program

$ELV
Insider Purchases

Director Collis Steven H bought $869,520 worth of shares (3,000 units at $289.84), increasing direct ownership by 469% to 3,639 units (SEC Form 4)

Director Devore Susan D. bought $374,580 worth of shares (1,200 units at $312.15), increasing direct ownership by 52% to 3,502 units (SEC Form 4)

President and CEO Boudreaux Gail bought $2,438,951 worth of shares (8,500 units at $286.94), increasing direct ownership by 6% to 151,020 units (SEC Form 4)

$ELV
Large Ownership Changes